참고문헌
- Calvo A, Yokoyama Y, Smith LE, et a1 (2002). Inhibition of the mammary carcinoma angiogenic switch in C3 (1)/SV40 transgenic mice by a mutated form of human endostatin. Int J Cancer, 101, 224-34. https://doi.org/10.1002/ijc.10589
- Cui L, Liu XX, Jiang Y, et al (2014). Phase II study on dose escalating schedule of paclitaxel concurrent with radiotherapy in treating patients with locally advanced non-small cell lung cancer. Asian Pac J Cancer Prev, 15, 1699-702. https://doi.org/10.7314/APJCP.2014.15.4.1699
- Dass CR, Choong PF (2008). Cancer angiogenesis: targeting the heel of Achilles. Drug Target, 16, 449-54. https://doi.org/10.1080/10611860802088523
- Dong X P, Xiao T H, Dong H, et al (2013). Endostar combined with cisplatin inhibits tumor growth and lymphatic metastasis of lewis lung carcinoma xenografts in mice. Asian Pac J Cancer Prev, 14, 3079-83. https://doi.org/10.7314/APJCP.2013.14.5.3079
- Fei ZH, Yao CY, Yang XL, et al (2013). Serum BMP-2 up-regulation as an indicator of poor survival in advanced non-small cell lung cancer patients. Asian Pac J Cancer Prev, 14, 5293-9. https://doi.org/10.7314/APJCP.2013.14.9.5293
- Felip E, Rosell R (2002). Neoadjuvant chemotherapy in non-small cell lung cancer. Curr Med Chem, 9, 893-8. https://doi.org/10.2174/0929867024606768
- Folkman J (1971). Tumor angiogenesis: therapeutic implications. N Engl J Med, 285, 1182-6. https://doi.org/10.1056/NEJM197111182852108
- Folkman J (2006). Anti-angiogenes in cancer theraphy-endostatin and its mechanisms of action. Expt Cell Res, 312, 594-607. https://doi.org/10.1016/j.yexcr.2005.11.015
- Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx.
- Hou ZB, Lu KJ, Wu XL, et al (2014). In vitro and in vivo antitumor evaluation of berbamine for lung cancer treatment.Asian Pac J Cancer Prev, 15, 1767-9. https://doi.org/10.7314/APJCP.2014.15.4.1767
- Huang G, Chen L (2010). Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma. J Cancer Res Clin Oncol, 136, 1201-11. https://doi.org/10.1007/s00432-010-0770-6
- Huang XE, Tian GY, Cao J, et al (2014). Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 6663-7.
- Ji ZQ, Huang XE, Wu XY, et al (2014). Safety of Brucea javanica and cantharidin combined with chemotherapy for treatment of NSCLC patients. Asian Pac J Cancer Prev, 15, 8603-5. https://doi.org/10.7314/APJCP.2014.15.20.8603
- Jiang XD, Dai P, Qiao Y, et al (2012). Clinical study on the recombinant human endostatin regarding improving the blood perfusion and hypoxia of non-small-cell lung cancer. Clin Transl Oncol, 14, 437-43. https://doi.org/10.1007/s12094-012-0821-3
-
Lu YY, Huang XE, Cao J, et al (2013). Phase II study on Javanica oil emulsion injection (Yadanzi
$^{(R)}$ ) combined with chemotherapy in treating patients with advanced lung adenocarcinoma. Asian Pac J Cancer Prev, 14, 4791-4. https://doi.org/10.7314/APJCP.2013.14.8.4791 - Kaya M, Wada T, Nagoya S, et al (2007). Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin. J Orthop Sci, 12, 562-7. https://doi.org/10.1007/s00776-007-1179-1
- Kirsch M, Strasser J, Allende R, et al (1998). Angiostatin suppress malignant glioma growth in vivo. Cancer Res, 58, 4654-9.
- Li N, Zheng DW, Wei XY, et al (2012). Effects of recombinant human endostatin and its synergy with cisplatin on circulating endothelial cells and tumor vascular normalization in A549 xenograft murine model. J Cancer Res Clin Oncol, 138, 1131-44. https://doi.org/10.1007/s00432-012-1189-z
- Liu ZJ, Wang J, Wei XY, et al (2012). Predictive value of circulating endothelial cells for efficacy of chemotherapy with Rh-endostatin in non-small cell lung cancer. J Cancer Res Clin Oncol, 138, 927-37. https://doi.org/10.1007/s00432-012-1167-5
- Macpherson GR, Ng SS, Forbes SL, et al (2003). Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay. Mol Cancer Ther, 2, 845-54.
- Peng XC, Qiu M, Wei M, et al (2012). Different combination schedules of gemcitabine with endostar affect antitumor efficacy. Cancer Chemother Pharmacol, 69, 239-46. https://doi.org/10.1007/s00280-011-1695-8
- Rong B, Yang S, Li W, et al (2012). Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer. World J Surg Oncol, 10, 170. https://doi.org/10.1186/1477-7819-10-170
- Rosell R, Felip E, Maestre J, et al (2001). The role of chemotherapy inearly non-small-cell lung cancer management. Lung Cancer, 34, S63-S74. https://doi.org/10.1016/S0169-5002(01)00376-2
- Scappaticci FA, Fehrenbacher L, Cartwright T (2005). Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol, 91, 173-80. https://doi.org/10.1002/jso.20301
- Shojaei F, Ferrara N (2008). Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenenic therapies. Drug Resist Updat, 11, 219-30. https://doi.org/10.1016/j.drup.2008.09.001
- Sim BKL, O, Reilly MS, Liang H, et al (1997). A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res, 57, 1329-34.
- Tatyana L, Diptiman C, Lisa K, et al (2007). Effects 0f sustained antiangiogenic therapy in multistage prostate cancer in TRAMP model. Cancer Res, 67, 5789-97. https://doi.org/10.1158/0008-5472.CAN-06-3637
- Te Velde EA, Reijerkerk A, Brandsma D, et al (2005). Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells. Br J Cancer, 92, 729-35. https://doi.org/10.1038/sj.bjc.6602385
- Tsunemi T, Nagoya S, Kaya M, et al (2003). Postoperative progression of pulmonary metastasis in osteosarcoma. Clin Orthop Relat Res, 407, 159-66. https://doi.org/10.1097/00003086-200302000-00024
- Wang HL, Ning T, Li M, et al (2011). Effect of endostatin on preventing postoperative progression of distant metastasis in a murine lung cancer model. Tumori, 97, 787-93.
- Wang JW, Sun Y, Liu YY, et al (2005). Results of randomized, multicenter, double-blind phase III trial of rh-endostatin (YH-16) in treatment of advanced non-small cell lung cancer patients. Chin J Lung Cancer, 8, 283-90.
- Wu HT, Deng J, Yu SY, et al (2010). The Inhibitory Effects of Rh-endostatin (YH-16) in Combination with Radiotherapy on lung adenocarcinoma A549 in Mice and the Underlying Mechanisms. J Huazhong Univ Sci Technol, 30, 108-12. https://doi.org/10.1007/s11596-010-0120-6
- Xia H, Luo L M, Fan Y F, et al (2003). Inhibitory effect of recombinant human endostatin on angiogenesis and lung metastasis of mouse lung adenocarcinoma, LA795. J First Mil Med Univ, 23, 30-3.
- Yan HA, Shen K, Huang XE (2013). Clinical study on mannan peptide combined with TP regimen in treating patients with non-small cell lung cancer. Asian Pac J Cancer Prev, 14, 4801-4. https://doi.org/10.7314/APJCP.2013.14.8.4801
- Yao HC, Jin DJ, Sun YN, et al (2004). Endostatin in the treatment of the transplantable model of human laryngeal squamous carcinoma in nude mice. Chinese J Otorhinolaryngol, 39, 394-8.
피인용 문헌
- antitumor effect of endostatin-loaded chitosan nanoparticles combined with paclitaxel on Lewis lung carcinoma vol.24, pp.1, 2017, https://doi.org/10.1080/10717544.2017.1378938
- The antitumour effects of eudesmin on lung cancer by inducing apoptosis via mitochondria-mediated pathway in the tumour cells vol.55, pp.1, 2017, https://doi.org/10.1080/13880209.2017.1401647